Latest News
Breakthrough T1D and Walgreens Foundation join forces to support the type 1 diabetes community
13 November 2026 - New York-based global type 1 diabetes (T1D) research and advocacy organisation Breakthrough T1D and the Walgreens Foundation announced on Thursday a new national partnership supporting Breakthrough T1D's mission and advancing ...
Sunnyside adds GLP-1 options to its medication program for Alcohol Use Disorder
13 November 2026 - Sunnyside, a US-based Alcohol Use Disorder (AUD) treatment and prevention company, announced on Thursday the launch of two new programs that pair semaglutide, a GLP-1 medication, with naltrexone, a medication FDA-approved for alcoh...
PAI Pharma acquires Nexus Pharmaceuticals
13 November 2026 - PAI Pharma (PAI), a portfolio company of Olympus Partners and a US-based developer, manufacturer, and marketer of oral liquid medicines and Ready-To-Use (RTU) sterile injectables, announced on Thursday the acquisition of Nexus Phar...
Lilly breaks ground on Lehigh Valley, Pennsylvania obesity medicine manufacturing site
13 November 2026 - Eli Lilly and Company (NYSE: LLY), a US-based pharmaceutical company, broke ground on a USD3.5bn manufacturing facility in Pennsylvania's Lehigh Valley on Thursday.Located in Fogelsville, Pennsylvania, the Lehigh Valley site i...
Innovent Biologics presents preclinical data for IL-6/TL1A bispecific antibody IAR177
13 November 2026 - Innovent Biologics, Inc. (HKEX: 01801), a China-based biopharmaceutical company that develops, manufactures, and commercialises medicines for the treatment of oncology, autoimmune, cardiovascular, and metabolic, ophthalmology, and ...